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Acute tubular Injury is Associated 
With severe traumatic Brain Injury: 
in Vitro study on Human tubular 
epithelial Cells
Federica Civiletti1, Barbara Assenzio1, Anna teresa Mazzeo1, Davide Medica2, Fulvia Giaretta2, 
Ilaria Deambrosis2, Vito Fanelli1, Vito Marco Ranieri5, Vincenzo Cantaluppi2,3 & 
Luciana Mascia1,4
Acute kidney injury following traumatic brain injury is associated with poor outcome. We investigated 
in vitro the effects of plasma of brain injured patients with acute tubular kidney injury on kidney tubular 
epithelial cell function. we performed a prospective observational clinical study in ICU in a trauma 
centre of the University hospital in Italy including twenty-three ICU patients with traumatic brain injury 
consecutively enrolled. Demographic data were recorded on admission: age 39 ± 19, Glasgow Coma 
Score 5 (3–8). Neutrophil Gelatinase-Associated Lipocalin and inflammatory mediators were measured 
in plasma on admission and after 24, 48 and 72 hours; urine were collected for immunoelectrophoresis 
having healthy volunteers as controls. Human renal proximal tubular epithelial cells were stimulated 
with patients or controls plasma. Adhesion of freshly isolated human neutrophils and trans-epithelial 
electrical resistance were assessed; cell viability (XTT assay), apoptosis (TUNEL staining), Neutrophil 
Gelatinase-Associated Lipocalin and Megalin expression (quantitative real-time PCR) were measured. 
All patients with normal serum creatinine showed increased plasmatic Neutrophil Gelatinase-
Associated Lipocalin and increased urinary Retinol Binding protein and α1-microglobulin. Neutrophil 
Gelatinase-Associated Lipocalin was significantly correlated with both inflammatory mediators 
and markers of tubular damage. Patient’ plasma incubated with tubular cells significantly increased 
adhesion of neutrophils, reduced trans-epithelial electrical resistance, exerted a cytotoxic effect and 
triggered apoptosis and down-regulated the endocytic receptor Megalin compared to control. plasma 
of brain injured patients with increased markers of subclinical acute kidney induced a pro-inflammatory 
phenotype, cellular dysfunction and apoptotic death in tubular epithelial cells.
In patients with traumatic brain injury (TBI), outcome is highly influenced by non-neurological complica-
tions1–3 including acute kidney injury (AKI)4. Recent studies reported an incidence of AKI equal to 8–20% in 
TBI patients5,6 using serum creatinine increase and urine output decrease as criteria for AKI. However it has 
been reported that 15–20% of patients who do not fulfill these criteria are likely to have acute tubular damage, a 
condition recently defined as “subclinical AKI”7.
In severe brain injured patients, a systemic inflammatory reaction, triggered by the primary injury and 
associated with secondary insults8, is mediated by the release of both pro- and anti- inflammatory cytokines 
and chemokines9–12. Interleukin-6 (IL-6), up-regulated in human serum and cerebrospinal fluid following 
TBI13–15, is also expressed in renal tubular epithelial cells during AKI, promoting neutrophil infiltration and 
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exacerbating renal injury16. Consequently, systemic inflammation occurring after TBI has been proposed as a 
possible mechanism of AKI causing functional alterations and apoptosis of tubular epithelial cells similarly to the 
sepsis-associated AKI. Nevertheless in brain injured patients cellular mechanisms of subclinical AKI have not 
been fully elucidated.
We hypothesized that following TBI, tubular cells represent a target of the inflammatory reaction leading to a 
consequent cellular dysfunction. To test this hypothesis, we performed a prospective observational clinical study 
to identify severe TBI patients with subclinical AKI and increased inflammatory reaction. In the in vitro study, we 
exposed human kidney-derived tubular epithelial cells to plasma of TBI patients with evidence of subclinical AKI.
Methods
Clinical study. The Institutional Review Board (Comitato Etico Interaziendale AUO Città della Salute e della 
Scienza di Torino, Italy) approved this prospective observational study. If the patients were incompetent, they 
were included into the study and informed consent was delayed. The family was informed of the study (although 
not required). Written informed consent for using collected data was hence obtained from the patient (if compe-
tent) or from the family (in case of death or if the patient remained incompetent). All methods were performed in 
accordance with the relevant guidelines and regulations.
All patients with severe TBI consecutively admitted to the NeuroIntensive Care Unit at the Trauma Center 
of the “Azienda Ospedaliera Univerisitaria Città della Salute e della Scienza di Torino” were included as part 
of a European network for high resolution data collection after TBI, the Brain Monitoring with Information 
Technology17, during 18 months from September 2011 up to March 2013.
Inclusion criteria were age older than 18 years and severe traumatic brain injury (Glasgow Coma Score lower 
than 9). The severity of brain injury defined as GCS < 9 was confirmed after patient stabilization in ICU.
Exclusion criteria were GCS = 3, history of known chronic kidney disease (eGFR < 60 ml/min: Chronic 
Kidney Disease Epidemiology Collaboration (CKD-EPI) formula18) including diabetes; patients with extracra-
nial injuries causing severe hemorrhagic shock and requiring transfusion on admission; immunosuppression, 
pregnancy, lack of consent.
Clinical management. Patients were managed according to the Brain Trauma Foundation Guidelines19. All 
patients were sedated, intubated and mechanically ventilated. Glasgow Coma Scale (GCS), Injury Severity Score 
(ISS) for the assessment of multiple injuries, Acute Physiology and Chronic Health Evaluation score (Apache II) 
to quantify the severity of illness and Marshall scale to classify head CT scan lesions were recorded on admission.
During the ICU stay, patients were continuously monitored to detect episodes of secondary insults (i.e. hypo-
tension). Acute kidney injury (AKI) was assessed using the RIFLE criteria: serum creatinine (SCr) and 24 hrs 
urine output20, haemoglobin, white blood cell count.
Study protocol. Blood samples for analysis of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and cytokine 
levels were collected at the time of inclusion (T0), at T24, T48 and T72 h. All plasma samples were centrifuged 
and then frozen at −80 °C until analyzed.
For the quantitative measurement of NGAL concentration (range from 60 to 1,300 ng/ml), the Triage® NGAL 
test was used, a fluorescence-based immunoassay used in conjunction with the Triage Meter (Biosite Inc., San 
Diego, CA), a fluorescence spectrometer.
The Bioplex assay for 27 cytokines was carried out in 96-well microplates using the Bio-Plex Pro Human 
Cytokine 27-plex Assay kit (Code M50-0KCAF0Y, Bio-Rad Laboratories version 6.1 with five-parametric curve 
fitting) at the Bioclarma - Research and Molecular Diagnostics, Torino, Italy. Plasma samples were diluted at 1:4 
and run in duplicate.
Urine immunoelectrophoresis: Urine samples were collected at T48 for the evaluation of proteinuria; due 
to the emergency admission it was not possible to perform this analysis on fresh urine samples at T0 and on 
T48 were available in 10 patients. Determination of proteinuria was performed by the Hydragel 5 Proteinurie 
KIT (Sebia, Norcross, GA). Electrophoresis on neutral buffered SDS-agarose gels separated the urinary proteins 
by molecular weight and distinguished the proteins of tubular (<70 kDa: i.e alpha1-microglobulin and retinol 
binding protein (RBP)) and glomerular (>70 kDa) origin. The resulting electrophoretic patterns, stained with 
acid violet, were visually compared to molecular weight protein markers in the reference track to identify the 
individual proteins and thus classify proteinuria. Pooled samples for age- and gender-matched healthy volunteers 
served as controls.
In vitro study. Isolation and culture of human proximal tubular epithelial primary cultures (PTEC). PTEC 
were obtained from normal cortex fragments of surgically removed kidneys. Immortalized tubular cell line is 
generated by infection with a hybrid Adeno5/SV40 virus as previously described21,22.
Cell cultures were maintained in RPMI (Gibco BRL Life Technologies Inc., Gaithersburg, MD) containing 
10% of fetal bovine serum (Gibco BRL Life Technologies Inc.) at 37 °C in humidified air with 5% CO2. PTEC were 
stimulated with 10% of patients’ plasma. Plasma from healthy volunteers were used as control. Optimal plasma 
percentage was determined on the basis of previous studies conducted in our laboratory23. In all the parts of the in 
vitro study PTEC monolayers were incubated with 10% TBI patients’ or healthy volunteers’ plasma.
Neutrophil adhesion assay. Neutrophils were isolated from healthy adult volunteer’s blood sample according to 
published methods24.
Whole blood added with EDTA was collected, layered over a density gelatin gradient and centrifuged. The 
neutrophil layer was aspirated and residual erythrocytes lysed. Cells were then washed, counted and re-suspended 
in buffer to obtain the desired concentration. Neutrophils were labeled with PKH26 red fluorescent cell linker kit 
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(Sigma Chemical Co., Crailsheim, Germany). Confluent monolayers of PTEC in 48-well plates were previously 
incubated with 10% of TBI or healthy plasma for 8 hours. PKH26-labeled PMN were added to the monolayers 
and the plates were incubated at 37 °C with 5% CO2. After 30 minutes, non-adherent cells were removed and the 
monolayers were washed several times with 1X PBS. At this point, adhered PMN were counted using a fluores-
cence microscope.
Cell polarity assay. Cell polarity was assessed by Trans-Epithelial Electrical Resistance (TEER) and by expression 
of proteins typical of fully differentiated PTEC such as the endocytic receptor megalin23.
PTEC were plated on Transwells® collagen-coated polycarbonate membranes (Corning Costar Corp., 
Cambridge, MA) and allowed to reach confluence before the addition of 10%of TBI patients’ plasma or control 
healthy plasma incubated for 12 h. An epithelial volt-ohm meter (EVOM, World Precision Instruments, Inc. 
Sarasota, FL. USA) was used to determine TEER values. All measurements were performed in triplicate for each 
well, normalized for the area of the membrane used in the experimental procedure and expressed as ohm/cm2.
Quantitative real-time (qRT-PCR) analysis for Megalin and NGAL. Total RNA was extracted using the RNeasy 
Mini Kit (Qiagen, Chatsworth, CA, USA).
RNA yield and quality was determined using a NanoDrop Spectrophotometer (NanoDrop Technologies, 
Wilmington, Delaware USA). Complementary cDNA was generated by reverse transcription of 2 μg of high 
quality total RNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster 
City, CA). The measurement of Megalin and NGAL mRNA levels was performed by SYBR green qRT-PCR 
analysis using the ABI Prism 7900 Sequence Detection System (Applied Biosystems, Foster City, CA) and 
SYBR FAST (Applied Biosystems, Foster City, CA). The following primers were used: Megalin forward 
5′GCCGATGCATTTATCAAAAC3′, Megalin reverse 5′TCACATCCATCTTCATCTCC3′, NGAL forward 
5′GGAAAAAGAAGTGTGACTACTG3′, NGAL reverse 5′GTAACTCTTAATGTTGCCCAG3′, GAPDH for-
ward 5′ACAGTTGCCATGTAGACC3′, GAPDH reverse 5′TTTTTGGTTGAGCACAGG3′ (Sigma Aldrich, St. 
Louis, Missouri, USA). Relative quantification was performed using the standard curve method. The results for 
the target gene expression were normalized on GAPDH as the endogenous control, and the mean values of the 
vehicle were set as the calibrator.
Cell viability assay. Cellular viability was studied by using the XTT-based colorimetric method (Trevigen 
Inc., Gaithersburg, MD), a sensitive kit for the measurement of cell proliferation based upon the reduction 
of the tetrazolium salt, 2, 3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide. The 
viability of the cells stimulated with TBI plasma was compared to that of the cells stimulated with healthy 
control plasma. Cells were seeded into 96-well plates with 150 μl of medium RPMI and incubated with 10% 
of TBI and control plasma for 24 hours. Then, XTT solution was added and the optical density was measured 
at 490 nm25.
Apoptosis assay. PTEC cells were exposed to 10% of TBI patients’ plasma for 48 hours. In all groups studied, 
apoptosis was assessed by terminal de-oxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay and 
by the detection of fragmented DNA using the ApopTag® Plus In Situ Apoptosis Fluorescein Detection Kit 
(Millipore, Billerica, MA)25.
statistical analysis. Continuous data are presented as mean and standard deviation or median and range. 
Correlation between plasmatic NGAL and cytokines or proteinuria was performed by linear regression analysis. 
Data normally distributed were analyzed by Student’s t-test, and data not normally distributed were analyzed 
using a Mann-Whitney U or Kruskal-Wallis test. Differences were considered significant when the probabil-
ity value was <0.05. Statistical analysis was performed using SPSS-statistical software, version 21.0 (SPSS Inc. 
Chicago, IL).
Results
Clinical study. Twenty-three adult severe TBI patients (19 males and 4 females) were enrolled in this study 
over a period of 30 months. Forty-three trauma patients were screened for eligibility (see Fig. 1: consort diagram). 
Demographic data are reported in Table 1. According to the ISS some of the patients had extracranial injuries but 
in none of them these injuries caused episodes of severe hypotension and none required transfusion. Therefore 
we excluded that acute kidney injury could be related to extracranial injuries. No patients developed AKI or were 
considered at risk according with RIFLE criteria: on T48 NGAL was elevated in 40%, RBP in all patients, α1-mi-
croglobulin in 10% and albumin in 90% of the patients compared to controls (Table 2).
Among the measured cytokines (data partially published in a previous study26) those with the strongest cor-
relation with markers of tubular damage were selected for the present analysis. Plasmatic NGAL and inflam-
matory mediator levels collected on T48 were significantly correlated: NGAL vs IL-6 (R2 = 0.61, p < 0.0001), 
NGAL vs MCP-1 (R2 = 0.45, p < 0.0005) and NGAL vs MIP-1β (R2 = 0.6, p < 0.0001; Fig. 2a–c). Plasma NGAL 
levels were also significantly correlated with total proteinuria values and markers of tubular damage: protein-
uria (R = 0.63, p = 0.006), α1-microglobulin (R = 0.51, p = 0.02) and RBP (R = 0.48, p = 0.02) respectively 
(Fig. 3a–c; n = 10).
In vitro study on proximal tubular epithelial cells (PTEC). PMN adhesion significantly increased after 
stimulation of PTEC with TBI plasma compared to control (Fig. 4, p = 0.001).
PTEC stimulated for 12 hours with TBI plasma showed significantly reduced levels of TEER compared to 
control plasma (Fig. 5a, p = 0.003).
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Megalin mRNA was significantly down-regulated after incubation with TBI compared to control plasma 
(Fig. 5b, p = 0.008).
After 24 hours of incubation, TBI plasma induced a significant cytotoxic effect on cultured PTEC compared 
to control plasma as detected by the XTT-based assay (Fig. 6a, p = 0.0001). The cytotoxic effect exerted by TBI 
plasma on PTEC was ascribed to the triggering of the apoptotic pathway as confirmed by evaluation of DNA frag-
mentation by TUNEL assay. Indeed, exposure of PTEC for 48 hours to TBI plasma induced a significant increase 
of apoptosis compared to control plasma (Fig. 6b, p = 0.0001).
Discussion
This study demonstrates for the first time that patients with TBI exhibited both increased urinary levels 
of low molecular weight proteins and plasmatic NGAL even though serum creatinine levels were normal. 
These markers were positively correlated with inflammatory mediators, suggesting the presence of tubular 
dysfunction related to the inflammatory reaction. In the in vitro study, plasma of TBI patients induced func-
tional alterations and apoptosis of human tubular epithelial cells. Some patients had extracranial injuries, 
but they were never responsible for severe hypotension requiring transfusion and consequently acute kidney 
injury.
These results suggest that the presence of acute cerebral damage makes the kidney vulnerable for tubular 
dysfunction (the so called “subclinical AKI”) and that tubular injury is probably associated with the severity 
of the systemic inflammatory response. Indeed plasma NGAL and low molecular weight proteinuria were 
significantly increased compared to controls even if biomarkers currently used for diagnosis and risk of 
AKI (i.e. serum creatinine and estimated glomerular filtration rate (eGFR))26–31 were not altered. NGAL is 
Figure 1. Patient enrollment flow diagram. Fourthy-three trauma patients were screened and 20 were excluded 
for the following reasons: 15 did not meet inclusion criteria for previous kidney disease (n = 5), for severe 
hemorrhagic shock (n = 10), in 3 was not possible to obtain consent and 2 for logistic problems.
Patients variables (n = 23) values
Age (yrs) mean (SD) 39 (19)
ISS mean (SD) 28 (11)
Apache II mean (SD) 15 (3)
GCS median (IQR) 5 (6; 3)
GCSm median (IQR) 2 (4; 1)
Marshall scale median (IQR) 4 (5; 3)
Table 1. Demographic data of the patient population. ISS injury severity score, Apache II Acute Physiology 
and Chronic Health Evaluation score, GCS Glasgow coma scale, GCSm Glasgow coma scale, motor score, TBI 
traumatic brain injury.
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released by neutrophils, hepatocytes and epithelial cells during inflammation and/or injury. This protein has 
been proposed as biomarker of AKI being up-regulated in the distal tubules early after ischemic and toxic 
injury32.
The increased plasmatic NGAL concentrations observed in the present study could be related to the inflam-
matory reaction occurring after TBI as well as to the development of AKI. The parallel increase of NGAL levels 
and proteinuria suggested the presence of a subclinical form of AKI. Indeed α-1microglobulin and RBP are 
low molecular weight proteins able to pass across the glomerular membrane into the Bowman’s capsule and 
then re-adsorbed by the proximal tubule through a mechanism involving the endocytic receptor megalin33. The 
presence of low molecular weight proteinuria in TBI patients confirmed the putative presence of an ongoing sub-
clinical AKI associated with tubular dysfunction. In future larger studies including patients with increased serum 
creatinine it would be interesting to investigate if there is a threshold level of NGAL corresponding to increased 
creatinine level.
The damage of tubular epithelial cells represents a hallmark of both ischemic and nephrotoxic AKI. Although 
several clinical studies reported an increased incidence of AKI in TBI patients, the mechanisms of renal damage 
have not been fully elucidated. Indeed, AKI develops even without severe episodes of hypoperfusion or exposure 
to nephrotoxins and tubular injury may be correlated to TBI-associated systemic inflammation and secondary 
organ damage.
On this basis, the mechanisms of TBI-associated renal dysfunction may be similar to those observed in 
experimental and clinical studies in patients with severe sepsis where AKI may be mainly ascribed to microvas-
cular derangement as well as to functional alterations of tubular epithelial cells including loss of solute carrier 
expression, bioenergetic alterations due to an impairment of mitochondrial function and, ultimately, apoptosis34. 
We previously found that plasma from patients with severe sepsis contains factors able to induce functional 
alterations of tubular and glomerular epithelial cells23. Part of inflammatory mediator data has been previously 
published from our group showing a significant correlation with secondary injury26. In the present study, we 
demonstrated that plasma from TBI patients vehicles molecules involved in the development of tubular dysfunc-
tion13,35. Moreover, it has been shown that IL-6 mediates a cytokine-dependent cell-mediated immune response 
that may exacerbate renal injury playing a critical role in the inflammatory response associated with AKI16. 
MCP-1 and MIP-1β are chemokines produced by leukocytes and endothelial cells during tissue injury: these 
molecules are involved in neutrophil infiltration attracting inflammatory cells from circulation into injured tis-
sues36. Viedt and coworkers demonstrated that MCP-1 activates human tubular epithelial cells leading to a time- 
and dose-dependent increase of IL-6 and ICAM-1 secretion. Moreover, apart from its chemoattractant activity, 
MCP-1 may further increase the inflammatory response by inducing cytokine release and adhesion molecule 
expression in tubular epithelial cells37.
In the in vitro study, PTEC were challenged with plasma of TBI patients in order to confirm the hypothesis 
of subclinical AKI generated by clinical observations. Plasma of TBI patients with subclinical AKI induced in 
PTEC neutrophil adhesion, altered permeability, neutrophil adhesion, reduced viability, enhanced apoptosis and 
increased expression of inflammatory molecules.
First, we found an increase in neutrophil adhesion to tubular epithelial cells. Adhesion is the initial stage 
of neutrophil trans-epithelial migration. Binding of neutrophils to the apical epithelium is known to be 
mediated by specific adhesion molecules such as ICAM1, expressed predominantly on the apical surface of 
epithelial cells38–40 and up-regulated in response to inflammatory stimuli38,39,41–43. It has been shown that neu-
trophils are able to injury the epithelium through several mechanisms, such as regulating disassembly of tight 
junctions, mechanical force, and degradative effects of soluble mediators including elastases, matrix metal-
loproteinases, defensins and oxidants44. Different studies provided evidence that neutrophil transmigration 
through an epithelial monolayer is sufficient by itself to trigger apoptotic cell death44,45. However, tubular cell 
apoptosis in the course of systemic inflammation can be ascribed to an alteration of mitochondrial biogenesis 
and function as well as to the presence of pro-apoptotic circulating mediators able to interact with specific 
Parameters Controls T0 T24 T48 T72
SOFA 6 ± 2 8 ± 2 8 ± 2 8 ± 2
RIFLE No risk No risk No risk No risk
IL-6 (pg/ml) 146 (27–757) 116 (20–1000) 79 (18–1597) 74 (19–1382)
MCP-1 (pg/ml) 99 (5–2164) 234 (43–3320) 287 (43–3318) 210 (38–3278)
MIP1-β (pg/ml) 107 (25–772) 98 (38–1042) 125 (42–908) 134 (39–921)
NGAL (ng/ml) <100 — 66 (17–337) —
Serum creatinine (mg/dl) 0.60–1.30 0.79 ± 0.16 0.73 ± 0.10 0.70 ± 0.15 0.70 ± 0.13
Proteinuria (mg/g urine creatinine) <100 — — 197 (40–793) —
Retinol Binding Protein (mg/g urine creatinine) <1 — — 5.1 (1–27) —
α1-microglobulin (mg/g urine creatinine) <14 — — 55 (3.6–212) —
Urinary albumin (mg/g urine creatinine) <20 — — 38.4 (25–76) —
Table 2. Renal function and inflammatory mediators in patient population. Data are presented as 
mean ± standard deviation (SD) or median and range. SOFA: Sequential Organ Failure Assessment; IL-6: 
interleukin 6; MCP1: monocyte chemoattractant protein 1; MIP1-β: macrophage inflammatory protein; NGAL: 
Neutrophil Gelatinase-Associated Lipocalin.
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receptors located on tubular cells46. In this study, we found that after long term incubation with TBI plasma, 
tubular cells underwent apoptosis. The persistence of apoptotic tubular injury may lead to the possible lack of 
tissue regeneration leading to a maladaptive repair: on this basis, innflammation may have a relevant role in 
the extension phase of AKI and progression toward fibrosis and consequent development of chronic kidney 
disease46. Infiltrating inflammatory cells may release an additional load of harmful mediators able to perpet-
uate tubular injury.
Polarity is a distinctive feature of epithelial cells mandatory to maintain two separate compartments with pre-
cise electrolyte concentrations. The mislocalization of specific solute carriers on tubular cell surface may lead to an 
increased influx of sodium and chloride in the distal tubule, thus leading to the triggering of tubulo-glomerular 
feedback with a consequent reduction of glomerular filtration rate. Moreover, the altered expression of other 
Figure 2. Correlation between concentration of plasmatic NGAL and inflammatory mediators. (n = 23): panel a) 
NGAL vs IL-6 (R2 = 0.53, p < 0.0001); panel b) NGAL vs MCP-1 (R2 = 0.45, p < 0.0001); panel c) NGAL vs MIP-1β 
(R2 = 0.6, p < 0.0001).
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molecules usually located on the apical surface of PTEC may be responsible for typical alterations such as protein-
uria observed in patients with sepsis and confirmed in our cohort of TBI patients.
Megalin is a multiligand, endocytic receptor expressed in kidney proximal tubule luminal membranes and 
apical endocytic compartment that is responsible for normal tubular reabsorption of several filtered proteins, 
mediating the recovery of essential substances that would be otherwise lost in the urine47. As we previously 
observed in septic patients with AKI, we found a significative decrease of megalin mRNA levels in PTECs incu-
bated with TBI plasma.
The presence of tubular cell dysfunction and apoptosis demonstrated in our in vitro study generates the 
hypothesis that subclinical AKI is underestimated in TBI patients using conventional biomarkers of renal func-
tion. This vulnerability of the kidney may evolve to clinical damage potentially leading to worse outcome.
Furthermore, almost 10% of severe brain damaged patients may evolve to brain death and then may become 
potential organ donors48,49. The presence of an unidentified and persistent tubular injury may therefore be 
Figure 3. Correlation between concentration of plasmatic NGAL and markers of tubular damage (n = 10): 
panel a) NGAL vs total proteinuria (R2 = 0.58, p = 0.006); panel b) NGAL vs α1-microglobulin (R2 = 0.46, 
p = 0.019); panel c) NGAL vs Retinol Binding Protein (R2 = 0.45, p = 0.02).
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clinically relevant in the setting of kidney transplantation. The tubular dysfunction associated with TBI may 
enhance kidney transplant damage due to ischemia-reperfusion injury and drug toxicity contributing to increase 
the incidence and duration of delayed graft function. On this basis, the use of functional and structural biomark-
ers of tubular damage in TBI patients should be encouraged.
Figure 4. Adhesion of neutrophils on PTEC monolayers incubated with 10% of TBI patients’ plasma (n = 23) 
compared to control group (n = 7) for 8 hours. Comparison between groups was made by unpaired t test 
(*p = 0.001; and data are presented as box plot with median and IQ1-IQ3).
Figure 5. Tubular dysfunction: panel a) alteration of PTEC polarity induced by TBI plasma incubation for 12 
hrs. Comparison between TBI and control groups was made by test U Mann-Whitney, unpaired (*p = 0.003). 
Panel b) qRT-PCR analysis of Megalin transcript levels in PTEC. Results were normalized to GAPDH 
expression. Comparison between TBI (n = 23) and control (n = 4) groups was made by test U Mann-Whitney, 
unpaired (*p = 0.008; data are presented as box plot with median and IQ1-IQ3).
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Limitations of the study. The main limitations of the present study are related to the small number of 
patients and to the co-presence of extracranial injuries.
 (a) In our patient population brain trauma was associated in more than 50% of the cases with extracranial 
injuries, but we did not include patients with severe hemorrhagic shock requiring transfusion to avoid 
that the severity of multiple trauma was the leading process starting inflammation and that a severe and 
prolonged hypothension was the main cause for tubular injury. Indeed it has been shown that in severe 
traumatic brain injured patients an inflammatory reaction is correlated both to the severity of primary in-
jury and to the secondary insults occurring during the ICU stay10,26. We therefore tested the hypothesis that 
the inflammatory reaction triggered by the brain trauma could contribute to the development of tubular 
damage.
 (b) We performed an observational study in a small number of patients, indeed only a low percentage de-
veloped AKI according to KDIGO criteria. Further studies including large cohort of severe brain injured 
patients are required to further elucidate the mechanism of tubular injury following traumatic brain injury.
Conclusions
To the best of our knowledge, we observed for the first time the consequence of TBI on renal function corre-
lated to the inflammatory process associated with brain injury. TBI triggers a complex cascade of molecular 
and cellular events associated with systemic inflammation and secondary distal organ damage. Circulating 
pro-inflammatory cytokines and chemokines such as IL-6, MCP-1 and MIP-1ß are potentially responsible for 
a hidden form of AKI that may progress toward chronic kidney disease without manifest signs. These consider-
ations are suggested both by the presence of increased levels of NGAL and low molecular weight proteinuria in 
the enrolled patients and by the evidence of tubular cell dysfunction and apoptosis induced in PTEC incubated 
with TBI plasma.
Figure 6. Tubular cells damage: Effect on PTEC viability (panel a) and apoptosis (panel b) after incubation with 
TBI plasma for 24 and 48 hrs respectively. Comparison between TBI (n = 23) and control (n = 6) groups was 
made by unpaired t test (*p = 0.0001; data are presented as box plot with median and IQ1-IQ3).
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